Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2008

01.10.2008 | Original Article

Idiopathic collapsing glomerulopathy in children

verfasst von: Ashima Gulati, Alok Sharma, Pankaj Hari, Amit K. Dinda, Arvind Bagga

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis (FSGS). Pathologically similar lesions have been reported in adults and children with human immuno-deficiency virus (HIV) infection. However, there is a recent interest in the recognition of this variant in the absence of HIV infection.

Aim

To evaluate the clinical presentation and outcome of our pediatric patients with idiopathic CG.

Methods

A sum of six children with idiopathic CG, aged 1–7 years at presentation, were retrospectively identified. Clinical data and renal biopsy were reviewed for all patients. Serum creatinine and estimated GFRs at presentation and last follow-up were compared using the Wilcoxon signed rank test and the risk factors for occurrence of ESRD analyzed using the Cox proportional hazard models.

Results

Steroid-resistant nephrotic syndrome with or without azotemia was the presenting clinical finding in all the cases. The median serum creatinine values at onset and last follow-up were 1.05 and 1.25 mg/dl, respectively (p = 0.128). Following immunosuppressive therapy one patient achieved complete remission of proteinuria, and four were in partial remission. The remaining one patient did not show any change in proteinuria at 6 months of therapy. Two of the six patients progressed to end-stage renal disease within a median follow-up period of 27 months (range 14–96 months).

Conclusions

Collapsing glomerulopathy is an aggressive variant of focal segmental glomerulosclerosis. All patients with CG should be screened for the underlying etiology, and patients with idiopathic CG should be offered a trial of immunosuppressive therapy.
Literatur
1.
Zurück zum Zitat Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000;15:1348–56.CrossRef Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000;15:1348–56.CrossRef
2.
Zurück zum Zitat D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43(2):368–82.CrossRef D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43(2):368–82.CrossRef
3.
Zurück zum Zitat Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int. 1999;56:2203–13.CrossRef Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int. 1999;56:2203–13.CrossRef
4.
Zurück zum Zitat Valeri A, Barisoni L, Appel GB, Seigle R, D’Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int. 1996;50:1734–46.CrossRef Valeri A, Barisoni L, Appel GB, Seigle R, D’Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int. 1996;50:1734–46.CrossRef
5.
Zurück zum Zitat Schwartz GJ, Haycock GB, Edelman CM, Spitzer A. A simple measure of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–63.PubMed Schwartz GJ, Haycock GB, Edelman CM, Spitzer A. A simple measure of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–63.PubMed
6.
Zurück zum Zitat Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH, National Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem. 2006;52:5–18.CrossRef Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH, National Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem. 2006;52:5–18.CrossRef
7.
Zurück zum Zitat Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007;72:1429–47.CrossRef Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007;72:1429–47.CrossRef
8.
Zurück zum Zitat Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int. 2004;66:1294–302.CrossRef Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int. 2004;66:1294–302.CrossRef
9.
Zurück zum Zitat Ponticelli C. Focal segmental glomerular sclerosis. To treat or not to treat? It is worthwhile to give the adult patient with nephrotic syndrome the benefit of an adequate therapeutic trial? Nephrol Dial Transplant. 1995;10:2351–4.CrossRef Ponticelli C. Focal segmental glomerular sclerosis. To treat or not to treat? It is worthwhile to give the adult patient with nephrotic syndrome the benefit of an adequate therapeutic trial? Nephrol Dial Transplant. 1995;10:2351–4.CrossRef
10.
Zurück zum Zitat Passerini P, Ponticelli C. Treatment of focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens. 2001;10:189–93.CrossRef Passerini P, Ponticelli C. Treatment of focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens. 2001;10:189–93.CrossRef
11.
Zurück zum Zitat Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol. 1998;9:1333–40.PubMed Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol. 1998;9:1333–40.PubMed
12.
Zurück zum Zitat Singh HK, Baldree LA, Mc Kenney DW, Hogan SL, Jennette JC. Idiopathic collapsing glomerulopathy in children. Pediatr Nephrol. 2000;14:132–7.CrossRef Singh HK, Baldree LA, Mc Kenney DW, Hogan SL, Jennette JC. Idiopathic collapsing glomerulopathy in children. Pediatr Nephrol. 2000;14:132–7.CrossRef
13.
Zurück zum Zitat El-Rafaey AM, Kapur G, Jain A, Hidalgo G, Imam A, Valentini RP, Mattoo TK. Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients. Pediatr Nephrol. 2007;22:396–402.CrossRef El-Rafaey AM, Kapur G, Jain A, Hidalgo G, Imam A, Valentini RP, Mattoo TK. Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients. Pediatr Nephrol. 2007;22:396–402.CrossRef
14.
Zurück zum Zitat Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int. 1994;45:1416–24.CrossRef Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int. 1994;45:1416–24.CrossRef
15.
Zurück zum Zitat Grcevska L, Polenakovik M. Collapsing glomerulopathy: clinical characteristics and follow-up. Am J Kidney Dis. 1999;33:652–7.CrossRef Grcevska L, Polenakovik M. Collapsing glomerulopathy: clinical characteristics and follow-up. Am J Kidney Dis. 1999;33:652–7.CrossRef
16.
Zurück zum Zitat Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 2002;62:2301–10.CrossRef Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 2002;62:2301–10.CrossRef
17.
Zurück zum Zitat Casado MC, Alarcon GV. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. Kidney Int. 2003;63:233–9.CrossRef Casado MC, Alarcon GV. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. Kidney Int. 2003;63:233–9.CrossRef
18.
Zurück zum Zitat Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int. 2004;66:1294–302.CrossRef Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int. 2004;66:1294–302.CrossRef
19.
Zurück zum Zitat Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71:1205–14.CrossRef Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71:1205–14.CrossRef
Metadaten
Titel
Idiopathic collapsing glomerulopathy in children
verfasst von
Ashima Gulati
Alok Sharma
Pankaj Hari
Amit K. Dinda
Arvind Bagga
Publikationsdatum
01.10.2008
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2008
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0053-6

Weitere Artikel der Ausgabe 5/2008

Clinical and Experimental Nephrology 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.